Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.68 - $11.07 $256,512 - $425,088
-38,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$6.26 - $11.03 $168,394 - $296,707
-26,900 Reduced 41.19%
38,400 $259,000
Q4 2020

Feb 16, 2021

SELL
$4.76 - $6.93 $131,852 - $191,961
-27,700 Reduced 29.78%
65,300 $448,000
Q3 2020

Nov 04, 2020

BUY
$4.71 - $7.36 $231,261 - $361,376
49,100 Added 111.85%
93,000 $520,000
Q2 2020

Jul 31, 2020

BUY
$3.61 - $6.47 $158,479 - $284,033
43,900 New
43,900 $229,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $950M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.